Janus Kinase (JAK) Inhibitor Market Forecast 2024-2034: Analyzes Trends Likely to Shape Future Opportunities
14 mars 2024 04h30 HE
|
Research and Markets
Dublin, March 14, 2024 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ...
Charting New Paths: Non-TNF's Evolving in Rheumatoid Arthritis Market
23 févr. 2024 13h50 HE
|
Spherix Global Insights
EXTON, PA, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Amidst the array of advanced treatment avenues available for rheumatoid arthritis (RA), ranging from legacy TNF inhibitors and their newer biosimilar...
When it Comes to Treating Ulcerative Colitis, US Gastroenterologists May be Betting it All on JAK…
30 nov. 2023 10h59 HE
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 30, 2023 (GLOBE NEWSWIRE) -- With the Ulcerative Colitis (UC) market set to heat up in the coming months, the JAK class seems poised to become a dominant treatment,...
XELJANZ for Ulcerative Colitis (UC) Pipeline Report 2023: Drug Market Insights and Forecasts, 2019-2032 - Focus on 7 Major Markets
23 nov. 2023 11h23 HE
|
Research and Markets
Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "XELJANZ Market Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. "XELJANZ Market Drug...
Eli Lilly's Olumiant and Pfizer's Litfulo Strengthen Alopecia Areata Arsenal, Yet Resounding Opportunity for JAK Expansion and New Assets in Development Remain
15 nov. 2023 11h22 HE
|
Spherix Global Insights
Exton, Pennsylvania, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Spherix Global Insights has been monitoring the alopecia areata (AA) market for the past four years and has found that the entry of JAK...
JAK Inhibitors Market Surges as Autoimmune Diseases Demand Cutting-Edge Solutions, 2032F: Revenues for Ruxolitinib, Tofacitinib, Oclacitinib, Baricitinib, Peficitinib, and Other Inhibitor Types
01 nov. 2023 08h18 HE
|
Research and Markets
Dublin, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The "Global Janus Kinase (JAK) Inhibitors Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global Janus Kinase (JAK)...
Global Tofacitinib Market Research Report 2023
17 oct. 2023 05h18 HE
|
Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Tofacitinib Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global tofacitinib market is expected to grow...
Pfizer’s Litfulo Poised to Follow Similar Trajectory as Eli Lilly/Incyte’s Olumiant for the Treatment of Severe Alopecia Areata
11 juil. 2023 09h58 HE
|
Spherix Global Insights
Exton, Pennsylvania, July 11, 2023 (GLOBE NEWSWIRE) -- In June 2022, Eli Lilly and Incyte’s Olumiant became the first and only approved advanced systemic treatment for adults with severe alopecia...
JAK Inhibitors Competitive Landscape 2023: Comprehensive Insights on 40+ Companies and 45+ Drug Profiles
08 mai 2023 06h38 HE
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "JAK inhibitors - Competitive Landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "JAK inhibitors - Competitive landscape,...
Global Atopic Dermatitis Drugs Market to 2030: Increasing Prevalence of Atopic Dermatitis Drugs Across the Globe Drives Growth
11 avr. 2023 11h43 HE
|
Research and Markets
Dublin, April 11, 2023 (GLOBE NEWSWIRE) -- The "Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report by Drug Class (Biologics, PDE4 Inhibitors), by Route Of Administration...